Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4826
PUT
Blackstone Secured Lending
BXSL
$5.75B
| $2.82M | ﹤0.01% |
96,200
+49,700
| +107% | +$1.5M |
|
4827
Seacoast Banking Corp of Florida
SBCF
$3.5B
| $2.82M | ﹤0.01% |
105,722
+4,242
| +4% | +$112K |
|
4828
Washington Trust Bancorp
WASH
$767M
| $2.82M | ﹤0.01% |
87,414
+3,784
| +5% | +$116K |
|
4829
CALL
Acadia Healthcare
ACHC
$2.87B
| $2.82M | ﹤0.01% |
44,400
+20,600
| +87% | +$1.49M |
|
4830
iShares Micro-Cap ETF
IWC
$1.52B
| $2.82M | ﹤0.01% |
22,829
-21,447
| -48% | -$2.59M |
|
4831
CALL
Azenta
AZTA
$1.46B
| $2.81M | ﹤0.01% |
58,100
+18,900
| +48% | +$983K |
|
4832
PUT
Immunovant
IMVT
$8.64B
| $2.81M | ﹤0.01% |
98,700
+39,500
| +67% | +$1.16M |
|
4833
CALL
Rollins
ROL
$17.4B
| $2.81M | ﹤0.01% |
55,600
-20,100
| -27% | -$993K |
|
4834
Chegg
CHGG
$87.5M
| $2.81M | ﹤0.01% |
1,588,424
+284,676
| +22% | +$697K |
|
4835
CALL
Bio-Rad Laboratories Class A
BIO
$9.53B
| $2.81M | ﹤0.01% |
8,400
+100
| +1% | +$31.8K |
|
4836
PUT
Vicor
VICR
$10.8B
| $2.81M | ﹤0.01% |
66,700
-1,000
| -1% | -$37.2K |
|
4837
PUT
Ingersoll Rand
IR
$32.3B
| $2.81M | ﹤0.01% |
28,600
+24,100
| +536% | +$2.24M |
|
4838
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$273M
| $2.81M | ﹤0.01% |
44,343
+40,949
| +1,207% | +$2.47M |
|
4839
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
$151M
| $2.81M | ﹤0.01% |
132,195
+71,346
| +117% | +$1.44M |
|
4840
CALL
Bio-Techne
TECH
$11.3B
| $2.81M | ﹤0.01% |
35,100
-8,400
| -19% | -$631K |
|
4841
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.09B
| $2.8M | ﹤0.01% |
106,247
+64,103
| +152% | +$1.66M |
|
4842
NextNav
NN
$3.36B
| $2.8M | ﹤0.01% |
374,452
-189,939
| -34% | -$1.47M |
|
4843
PUT
Corcept Therapeutics
CORT
$12.4B
| $2.8M | ﹤0.01% |
60,600
-10,400
| -15% | -$370K |
|
|
DCH
4844
CALL
Dauch Corp
DCH
$1.6B
| $2.8M | ﹤0.01% |
452,800
+323,500
| +250% | +$2.11M |
|
4845
CALL
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.8M
| $2.8M | ﹤0.01% |
47,910
+7,990
| +20% | +$485K |
|
4846
Charles River Laboratories
CRL
$13.4B
| $2.8M | ﹤0.01% |
14,197
-14,665
| -51% | -$3.05M |
|
4847
PUT
Service Corp International
SCI
$11.5B
| $2.79M | ﹤0.01% |
35,400
+6,800
| +24% | +$517K |
|
4848
Mizuho Financial
MFG
$132B
| $2.79M | ﹤0.01% |
668,281
+43,401
| +7% | +$181K |
|
4849
Lloyds Banking Group
LYG
$90.1B
| $2.79M | ﹤0.01% |
894,396
+727,781
| +437% | +$2.18M |
|
4850
PGIM Active High Yield Bond ETF
PHYL
$1.4B
| $2.79M | ﹤0.01% |
+77,844
| New | +$2.73M |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.